{"id":"NCT00346775","sponsor":"GlaxoSmithKline","briefTitle":"Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)","officialTitle":"A Randomized, Single-Blind, Cross-Over, Multicenter Study to Validate the Preference Module of the Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Administered to Adult Subjects With Seasonal Allergic Rhinitis During a Three-week Cross-over Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05-01","primaryCompletion":"2006-06-29","completion":"2006-06-29","firstPosted":"2006-06-30","resultsPosted":"2017-12-06","lastUpdate":"2018-01-16"},"enrollment":97,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis, Allergic, Perennial"],"interventions":[{"type":"DRUG","name":"Beclomethasone dipropionate","otherNames":[]},{"type":"DRUG","name":"Flunisolide","otherNames":["Beclomethasone dipropionate"]}],"arms":[],"summary":"The Protocol section needs to be updated using the following text \"The main goal of the study was to validate the Preference Module of the EARNS-Q and to test the reliability using Treatment Satisfaction Questionnaire for Medicines (TSQM), a validated questionnaire for determining satisfaction among different treatment. The EARNS-Q is divided into 2 modules, an Experience Module and a Preference Module. The Experience Module includes 28 items, fourteen attribute rating items followed by fourteen importance weighing questions. The Preference Module includes the same items along with preference questions related to each item as well as a global preference question.","primaryOutcome":{"measure":"Correlations of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Preference Module With Treatment Satisfaction Questionnaire for Medicines (TSQM) Change Scores and Change in Mean Daily Reflective Total Nasal Symptom (rTNSS) Scores","timeFrame":"Day 1 to Day 23","effectByArm":[{"arm":"Beconase + Nasarel","deltaMin":0.45,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":97},"commonTop":["Headache","Nasal discomfort","Nasal dryness","Eye infection","Upper respiratory tract infection"]}}